OverheardIntelligenceRequest Demo
Pharmaceutical & Biotech

Detect pipeline signals, KOL commentary, and competitive moves from medical conferences, investor days, and industry podcasts.

Conference season produces hundreds of hours of KOL presentations and panel discussions. Your medical affairs team can attend 5% of them. The rest is invisible.

See Your Industry Intelligence

How It Works

01
You tell us who to watch
Name your competitors, key topics, and target companies. We build a monitoring profile tailored to Pharma companies, biotech firms, and life sciences investors.
02
We monitor the conversations
Overheard processes medical conference recordings (ASCO, ESMO, JPM), pharma earnings calls, KOL podcast interviews, and more — extracting commercially relevant signals.
03
You get actionable intelligence
Weekly briefing with source-backed signal cards. Click any signal to hear the original audio moment.

Example Signals

Real-world examples of the intelligence Overheard detects for Pharma companies, biotech firms, and life sciences investors. Every signal links to the original audio source.

Competitive WeaknessHigh confidence

KOL expresses disappointment with Phase III data for competing oncology asset at ASCO side session

Oncologist · Chief of Oncology at academic medical center
Source: ASCO 2026 panel · Listen to original
Deal SignalHigh confidence

Biotech CEO reveals partnership discussions for late-stage rare disease asset

CEO · CEO at mid-cap biotech
Source: JPM Healthcare Conference · Listen to original
Regulatory SignalHigh confidence

Former FDA reviewer signals stricter endpoint requirements for CNS trials

Former Reviewer · Former FDA Division Director
Source: BioCentury podcast · Listen to original

Audio Sources We Monitor

medical conference recordings (ASCO, ESMO, JPM)pharma earnings callsKOL podcast interviewsinvestor day presentationsFDA advisory panels

Built For

Director of Competitive Intelligence, Medical Affairs Lead, or BD Analyst

at Top-50 pharma and mid-cap biotech

Frequently Asked Questions

How do pharmaceutical companies do competitive intelligence?+
Pharmaceutical CI teams monitor clinical trial registries, FDA filings, patent landscapes, and KOL publications. The most advanced teams also systematically track medical conference recordings and pharma podcasts, where KOLs and executives reveal trial sentiment, pipeline priorities, and partnership signals that precede formal disclosures.
What podcasts cover the pharmaceutical industry?+
Important pharmaceutical podcasts include BioCentury This Week, The Drug Development Podcast, Endpoints News, and Pharma Intelligence. Conference recordings from ASCO, ESMO, and JPM Healthcare are also rich sources of competitive intelligence, featuring KOL commentary and executive interviews about pipeline strategy.
How can I monitor pharmaceutical competitors?+
Effective pharma competitor monitoring combines traditional sources like SEC filings and ClinicalTrials.gov with audio intelligence from earnings calls, medical conferences, and industry podcasts. KOL commentary at conference side sessions often signals trial sentiment weeks before data readouts become public.
What intelligence can you get from pharma industry podcasts?+
Pharma podcasts and conference recordings surface KOL sentiment on clinical data, executive commentary on pipeline priorities, partnership discussions, and regulatory strategy signals. A KOL expressing disappointment with a competitor Phase III result at an ASCO panel is actionable intelligence that moves faster than any analyst report.

See Overheard for Pharmaceutical & Biotech

We'll build a custom intelligence briefing for your industry and competitors within 48 hours. No generic demo — real signals from real sources.

Free custom briefing. We'll reach out within 48 hours with real intelligence about your competitors.